C-REACTIVE PROTEIN - ANVISA Registration 10387650141

Access comprehensive regulatory information for C-REACTIVE PROTEIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10387650141 and manufactured by DXGEN CORP.. The registration is held by CAPRICORN TECHNOLOGIES DO BRASIL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including Nanosens Ltda, LABTEST DIAGNOSTICA S/A, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10387650141
Registration Details
ANVISA Registration Number: 10387650141
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Kit para teste Proteína C Reativa Epithod®
Risk Class II

Registration Details

10387650141

25351195053202345

02823683000102

Company Information

DXGEN CORP.
South Korea
PT: CORÉIA DO SUL

Dates and Status

May 02, 2023

VIGENTE

09/18/2025 19:00:01